4142:TPE
Adimmune Corp
NT$17.25
arrow_upward
+0.29%(+0.050) 1D
Nov 2, 1:30:07 PM GMT+8 · TWD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4142...
Open
NT$17.65
High
NT$17.65
Low
NT$17.25
Mkt. cap
7.41B
Avg. vol.
1.04M
Volume
731.10K
52-wk high
NT$22.50
52-wk low
NT$16.40
EPS
-NT$0.34
Shares outstanding
235.29M
No. of employees
564
Open
NT$17.65
High
NT$17.65
Low
NT$17.25
Mkt. cap
7.41B
Avg. vol.
1.04M
Volume
731.10K
52-wk high
NT$22.50
52-wk low
NT$16.40
EPS
-NT$0.34
Shares outstanding
235.29M
No. of employees
564
News stories
From web sources and news partners
bloomingbit
·
14 minutes ago
Morgan Stanley's Wilson Says US Stock Pullback Is Buying Opportunity, Sees S&P 500 Rising From 7,100 to 8,000
TradingView
·
1 hour ago
Stock Market: Will S&P 500 Open Up or Down Today?
Benzinga
·
9 minutes ago
S&P 500 Is Up '19 For 19 Times' In Midterm November-April Window, According To Ryan Detrick
The Motley Fool
·
4 hours ago
The S&P 500's Shiller P/E Is Above 40. History Says What Happened the Only Other Time.
Profile
Adimmune Corporation is a Taiwanese pharmaceutical company engaged in the research, development, manufacturing, and sales of medicines and vaccines for both humans and animals. Its products are supplied to both local and international markets.
Founded in 1965 and headquartered in Tanzi District, Taichung, it has a market cap of US$230 million, 564 employees and annual sales of $106 million as of 2026.
Adimmune continues to seek expansion its role in the regional pharmaceutical and vaccine industry through international collaborations.
In January 2021, Adimmune Corporation announced a partnership with Sam Chun Dang Pharm to jointly develop an injectable medication used to treat macular disease.
In July 2021, the company announced that its first overseas manufacturing site will be situated in the Special Economic Zone in East Java, Indonesia, aiming to launch clinical trials for its COVID-19 vaccine in Indonesia early 2022.
In August 2021, Adimmune Corporation signed a memorandum of understanding with Becton, Dickinson and Company to strengthen its international pharmaceutical collaboration. Wikipedia
About Adimmune Corp